In the event of a federal government shutdown, individuals enrolled in Apple Health (Medicaid), Public Employees Benefits Board, and School Employees Benefits Board coverage—and those accessing behavioral health services—will not experience a disruption in care. In addition, health care providers will continue to be paid for the services they provide.
If a shutdown occurs, we will share more information at that time.
Medications for opioid use disorder (MOUD) is an approach to opioid use treatment that combines the use of FDA-approved drugs with counseling and behavioral therapies for people diagnosed with opioid use disorder (OUD).
Find answers to your questions about buprenorphine-containing products in office-based opioid treatment settings in our COVID-19 and prescribing FAQ.
Medication for Opioid Use Disorder (MOUD) is used at opioid treatment program (OTP) facilities as a method for assisting patients in recovery. If you have a patient in need of these services, refer to our listing of opioid treatment programs (OTP) in Washington State.
In addition, the Washington State Targeted Response (STR): Hub and Spoke Project funds multiple, geographically-based, integrated networks of care — called hub and spoke networks — for OUD treatment.
Learn how to bill for primary care services in a substance use disorder setting and when offering MOUD services:
OTNs are second generation hub and spoke treatment sites that serve individuals with opioid use disorder. OTNs are positioned to provide MOUD in nontraditional treatment settings such as emergency departments, jails, syringe services, homeless shelters, and fire departments. These sites initiate medication treatment and make referrals to community providers for ongoing care.
Current OTNs in Washington are located at:
Megan Fowler
State Opioid Response (SOR) Treatment Manager
Email: megan.fowler@hca.wa.gov
Phone: 360-725-2019
